Chief scientist Shaw looks for unusual sources of return in MNKD and VRX.
Wednesday could mark a turning point for Synergy investors.
Written by Danny Cohen and Scott Matusow The biotech “run-up” trade has always attracted a wide-array of traders looking to take advantage of …
Before founding Zynex, Inc. (OTCMKTS:ZYXI) over two decades ago, Thomas Sandgaard was a man who had just moved to the U.
Is Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) “a ticking bomb” after new Danish CEO Kare Schultz has ordered a quarter of the Israeli …
This 50 billion-dollar fund is dropping VRX and turning to TEVA.
Why this Wall Street hedge fund legend sold VRX and GILD?
This billion-dollar hedge fund initiates new position in struggling pharma TEVA as exits VRX.
Is Billionaire fund guru Jim Simons switching OPK for VRX?
Ken Griffin is a man known to be raring to take a risk when it is worthwhile, a daring and strategic mindset that …